CAAS Capital Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-2,288
Closed -$165K – 917
2021
Q4
$210K Hold
2,288
– – 0.01% 660
2021
Q3
$290K Sell
2,288
-58,780
-96% -$8.56M 0.01% 701
2021
Q2
$10.2M Sell
61,068
-2,877
-4% -$466K 0.17% 146
2021
Q1
$11.6M Buy
63,945
+62,591
+4,623% +$14.5M 0.13% 193
2020
Q4
$271K Buy
+1,354
New +$275K ﹤0.01% 738

Other funds holding TDOC

CAAS Capital Management's TDOC Position: Q1 2022 in Review

CAAS Capital Management sold out of Teladoc Health (TDOC) in Q1 2022, closing a stake of 2,288 shares — an estimated $165K sold.

CAAS Capital Management first reported a position in TDOC in Q4 2020 and held it in 5 quarters. The position peaked at $11.6M in Q1 2021. 680 funds tracked by Wall St. Rank hold TDOC as of Q1 2022.

  • CAAS Capital Management reported no remaining Teladoc Health position as of Q1 2022 after selling out during the quarter.
  • CAAS Capital Management sold 2,288 Teladoc Health shares in Q1 2022, an estimated $165K.
  • CAAS Capital Management first reported a position in Teladoc Health in Q4 2020 and held it in 5 quarters.
  • CAAS Capital Management's Teladoc Health position peaked at $11.6M in Q1 2021.
  • 680 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2022.

Based on CAAS Capital Management's 13F filing for Q1 2022, filed 13 May 2022.